Internal Medicine, Nephrology · Salinas, CA
NPI
1437238342
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
917 Blanco Circle
Salinas, CA, 93901
Phone (831) 755-7999
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
108,673 services
Medicare patients, 2024
896
Average age 73
Drug cost, 2024
$540K
2,078 prescriptions
Company payments, 2025
$669
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dennis N Phan was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 18,870 times for 33 patients. In total Dennis N Phan billed 108,673 services in 81 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 18,870 | 33 | $0.26 | $4,981 |
| J1306 Injection, inclisiran, 1 mg | Office | 14,200 | 37 | $9.53 | $135K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 12,180 | 19 | $8.60 | $105K |
| J0897 Injection, denosumab, 1 mg | Office | 7,740 | 102 | $20.51 | $159K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,212 | 43 | $6.35 | $14K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 689 | 20 | $0.21 | $144 |
| 99232 Hospital E&M - Subsequent | Facility | 564 | 215 | $66.83 | $38K |
| 96372 Injection Administration | Office | 517 | 209 | $12.40 | $6,412 |
| 99214 Office E&M - Established | Office | 511 | 248 | $80.95 | $41K |
| 90960 ESRD Related Services (not dialysis) | Office | 383 | 59 | $319.76 | $122K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 258 | 174 | $12.27 | $3,165 |
| 36415 Venipuncture Blood Collection | Office | 191 | 121 | $8.57 | $1,636 |
| 96365 Intravenous Infusion, Hydration | Office | 175 | 78 | $55.02 | $9,629 |
| 90935 Hemodialysis | Facility | 173 | 96 | $59.92 | $10K |
| 99223 Hospital E&M - Initial | Facility | 129 | 106 | $148.29 | $19K |
By year: 2022 $1.0M for 63,621 services; 2023 $1.6M for 78,939 services; 2024 $2.0M for 108,673 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 191 | 121 | $8.57 | $1,636 |
| 80069 Clinical Chemistry | 125 | 99 | $8.45 | $1,056 |
| 85018 Blood Count | 92 | 14 | $2.32 | $213 |
| 85014 Blood Count | 45 | 11 | $2.32 | $104 |
| 83036 Blood Count | 31 | 25 | $9.52 | $295 |
| 80053 Clinical Chemistry | 26 | 22 | $9.98 | $259 |
Medicare prescription drug claims, 2024
In 2024, the drug Dennis N Phan prescribed most often to Medicare patients was Amlodipine Besylate, with 192 prescriptions and refills. In total Dennis N Phan wrote 2,078 Medicare prescriptions that cost $540K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 192 | 476 | 61 | $986 |
| Lisinopril Generic | 182 | 492 | 53 | $1,016 |
| Losartan Potassium Generic | 126 | 355 | 44 | $1,198 |
| Furosemide Generic | 96 | 272 | 36 | $522 |
| Jardiance Empagliflozin | 79 | 139 | 20 | $76K |
| Sevelamer Carbonate Generic | 72 | 144 | 25 | $15K |
| Paricalcitol Generic | 64 | 135 | 18 | $8,519 |
| Calcium Acetate Generic | 56 | 154 | 24 | $7,225 |
| Rayaldee Calcifediol | 55 | 55 | 11 | $67K |
| Farxiga Dapagliflozin Propanediol | 54 | 126 | 16 | $67K |
| Carvedilol Generic | 50 | 111 | 18 | $425 |
| Benazepril Hcl Generic | 49 | 134 | 17 | $675 |
| Atenolol Generic | 44 | 66 | Under 11 | $120 |
| Doxercalciferol Generic | 44 | 98 | 17 | $18K |
| Hydralazine Hcl Generic | 39 | 114 | 15 | $611 |
Brand drugs: 374 claims; generic drugs: 1,704 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dennis N Phan $669 ($669 in general payments such as food, travel and fees) from 13 companies. The largest payer was Calliditas Therapeutics US Inc. with $173.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 12 | $173 |
| Travere Therapeutics, Inc. TVTX | 5 | $114 |
| Fresenius USA Marketing, Inc. | 4 | $80.26 |
| Amgen Inc. AMGN | 4 | $76.29 |
| Mallinckrodt Hospital Products Inc. | 2 | $46.36 |
| Vifor Pharma, Inc. | 1 | $28.91 |
| Akebia Therapeutics Inc AKBA | 1 | $27.39 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $27.04 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $22.75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.